Fallopian Tube Carcinoma
📧 Sign up to get email alerts when something new happens for Fallopian Tube Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating genetically modified T cells in combination with decitabine for recurrent or refractory ovarian,…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with bevacizumab, with or without the anti-CD40 agonist CDX-1140, for recur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy [Phase 2]
Phase 2 trial evaluating a standardized AHCC extract in ovarian cancer patients on adjuvant chemotherapy; the study is currently active but …
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer [Phase 1]
A Phase 1 clinical trial of SCT-001 CAR T Cells Therapy for relapsed and refractory ovarian cancer and related peritoneal cancers is not yet…